Talk:Androgen replacement therapy/Diabetes and testosterone
In men over 45 are more likely, the risks of diabetes and of testosterone deficiency (in men, called hypogonadism or more specifically hypoandrogenism) are strongly correlated. Testosterone replacement therapies have been shown to improve blood glucose management.[1][2] Still, "it is prudent not to start testosterone therapy in men with diabetes solely for the purpose of improving metabolic control if they show no signs and symptoms of hypogonadism."[3]
Management guidelines for diabetes developed by expert groups in Europe and the United States are to some extent at odds with more recent Canadian consensus guidelines.[4][5]
See also edit
References edit
- ^ Morales (August 2010). "A practical guide to diagnosis, management and treatment of testosterone deficiency for Canadian physicians". Can Urol Assoc J. 4 (4): 269–75. PMC 2910774. PMID 20694106.
- ^ Francisco Jimenez-Trejo, Marco Cerbon, Sumiko Morimoto (2011). "Sex steroids effects in normal endocrine pancreatic function and diabetes". Current Topics in Medicinal Chemistry. 11 (13): 1728–1735. doi:10.2174/156802611796117540. PMID 21463250.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Basaria S (2014 Apr 5). "Male hypogonadism". Lancet. 383 (9924): 1250–63. doi:10.1016/S0140-6736(13)61126-5. PMID 24119423.
{{cite journal}}: Check date values in:|date=(help) - ^ Woo, V (2009). "Important differences: Canadian Diabetes Association 2008 clinical practice guidelines and the consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes". Diabetologia. 52 (3): 552–3, author reply 554–5. doi:10.1007/s00125-008-1236-0. PMID 19107458.
- ^ Nathan, DM; Buse, JB; Davidson, MB; Ferrannini, E; Holman, RR; Sherwin, R; Zinman, B; American Diabetes, Association; European Association for the Study of Diabetes (2009). "Medical management of hyperglycaemia in type 2 diabetes mellitus: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes". Diabetologia. 52 (1): 17–30. doi:10.1007/s00125-008-1157-y. PMID 18941734.
{{cite journal}}: Invalid|display-authors=9(help)